Stock Track | CHINARES PHARMA Soars 6.24% in Morning Session on Strong Annual Results with 20.73% Profit Jump

Stock Track03-26

CHINARES PHARMA's stock soared 6.24% during morning trading, driven by the release of its robust annual financial results.

The company reported group revenue of RMB 269.574 billion, a year-on-year increase of 4.62%, with profit attributable to shareholders reaching RMB 4.045 billion, up 20.73% compared to the previous year. Earnings per share were RMB 0.64, and a final dividend of RMB 0.122 per share was declared, representing an increase of approximately 135% year-on-year.

At the business level, the pharmaceutical segment recorded revenue growth of 10.2% year-on-year, while the pharmaceutical distribution business grew 3.2% and pharmaceutical retail operations surged 20.8%, driven by strong performance in the Direct-to-Patient (DTP) business.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1167223959?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-26 10:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167223959","market":"hk","top_or_hot":-1,"title":"Stock Track | CHINARES PHARMA Soars 6.24% in Morning Session on Strong Annual Results with 20.73% Profit Jump","media":"Stock Track","content":"<p>CHINARES PHARMA's stock soared 6.24% during morning trading, driven by the release of its robust annual financial results.</p><p>The company reported group revenue of RMB 269.574 billion, a year-on-year increase of 4.62%, with profit attributable to shareholders reaching RMB 4.045 billion, up 20.73% compared to the previous year. Earnings per share were RMB 0.64, and a final dividend of RMB 0.122 per share was declared, representing an increase of approximately 135% year-on-year.</p><p>At the business level, the pharmaceutical segment recorded revenue growth of 10.2% year-on-year, while the pharmaceutical distribution business grew 3.2% and pharmaceutical retail operations surged 20.8%, driven by strong performance in the Direct-to-Patient (DTP) business.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CHINARES PHARMA Soars 6.24% in Morning Session on Strong Annual Results with 20.73% Profit Jump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CHINARES PHARMA Soars 6.24% in Morning Session on Strong Annual Results with 20.73% Profit Jump\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-26 10:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CHINARES PHARMA's stock soared 6.24% during morning trading, driven by the release of its robust annual financial results.</p><p>The company reported group revenue of RMB 269.574 billion, a year-on-year increase of 4.62%, with profit attributable to shareholders reaching RMB 4.045 billion, up 20.73% compared to the previous year. Earnings per share were RMB 0.64, and a final dividend of RMB 0.122 per share was declared, representing an increase of approximately 135% year-on-year.</p><p>At the business level, the pharmaceutical segment recorded revenue growth of 10.2% year-on-year, while the pharmaceutical distribution business grew 3.2% and pharmaceutical retail operations surged 20.8%, driven by strong performance in the Direct-to-Patient (DTP) business.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03320","symbol_name":"华润医药","start_time":0,"source_url":"","article_id":"1167223959","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167223959","pubTimestamp":1774491882,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"CHINARES PHARMA's stock soared 6.24% during morning trading, driven by the release of its robust annual financial results.The company reported group revenue of RMB 269.574 billion, a year-on-year...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03320":"华润医药"},"translate_title":"股票追踪|CHINARES PHARMA早盘飙升6.24%，全年业绩强劲，利润跃升20.73%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":1},"content_text":"CHINARES PHARMA's stock soared 6.24% during morning trading, driven by the release of its robust annual financial results.The company reported group revenue of RMB 269.574 billion, a year-on-year increase of 4.62%, with profit attributable to shareholders reaching RMB 4.045 billion, up 20.73% compared to the previous year. Earnings per share were RMB 0.64, and a final dividend of RMB 0.122 per share was declared, representing an increase of approximately 135% year-on-year.At the business level, the pharmaceutical segment recorded revenue growth of 10.2% year-on-year, while the pharmaceutical distribution business grew 3.2% and pharmaceutical retail operations surged 20.8%, driven by strong performance in the Direct-to-Patient (DTP) business.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1167223959","isCrawlerRequest":true}